Jaguar Health (JAGX) Exchange Rate Effect (2022 - 2026)
Jaguar Health (JAGX) reported Exchange Rate Effect of $17000.0 for Q1 2026, down 52.78% year-over-year from $36000.0 in Q1 2025, and up 270.0% quarter-over-quarter from -$10000.0 in Q4 2025.
Jaguar Health (JAGX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 5 years of Exchange Rate Effect data on file, last reported at $17000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $17000.0, down 52.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$132000.0 (down 13300.0% YoY), and the FY2025 annual result was -$113000.0, down 109.26% from the prior year.
- Exchange Rate Effect advanced to $17000.0 in Q1 2026 per JAGX's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $57000.0 in Q2 2025 and troughed at -$196000.0 in Q3 2025.
- A 5-year average of -$7000.0 and a median of -$10000.0 in 2024 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 670.0% in 2025 and fell as far as 732.26% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $54000.0 in 2022, then decreased by 18.52% to $44000.0 in 2023, then plunged by 227.27% to -$56000.0 in 2024, then surged by 82.14% to -$10000.0 in 2025, then jumped by 270.0% to $17000.0 in 2026.
- Business Quant data shows JAGX's Exchange Rate Effect at $17000.0 in Q1 2026, -$10000.0 in Q4 2025, and -$196000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Sep 30, 2025 | -196,000.00 |
| Sep 30, 2025 | -196,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Dec 31, 2023 | 44,000.00 |